20 天
Zacks Investment Research on MSNVertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six months. A key reason for the stock price decline was unimpressive data from a phase II study on its key ...
The U.S. agency that oversees Medicare is taking out questions on enrollment application forms that ask people about their ...
Mitsui Seiki has evolved its popular "Vertex 550-5X" line of machines with new features and capabilities ... Fluid that reduces temperature buildup at the tool/workpiece interface during machining.
Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...
Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果